Computational analysis identifies a sponge interaction network between long non-coding RNAs and messenger RNAs in human breast cancer

BMC Systems Biology

Volumn 8, Issue 1, 2014, Pages

  Paci, Paola ^a   Colombo, Teresa ^a   Farina, Lorenzo ^b  

^a CNR   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Epigenetics; Networks analysis; Systems biology

Indexed keywords

LONG UNTRANSLATED RNA; MESSENGER RNA; MICRORNA;

BIOLOGY; BREAST TUMOR; GENE REGULATORY NETWORK; GENETICS; HUMAN; METABOLISM; PROCEDURES;

BREAST NEOPLASMS; COMPUTATIONAL BIOLOGY; GENE REGULATORY NETWORKS; HUMANS; MICRORNAS; RNA, LONG NONCODING; RNA, MESSENGER;

EID: 84904272774     PISSN: None     EISSN: 17520509     Source Type: Journal    
DOI: 10.1186/1752-0509-8-83     Document Type: Article

References (62)

1. Costa FF. Non-coding rnas, epigenetics and complexity. Gene 2008, 410(1):9-17.
2. Mattick JS. The genetic signatures of noncoding rnas. Plos Genet 2009, 5(4):10-1371.
3. Filipowicz W, Bhattacharyya SN, Sonenberg N.Mechanisms of post-transcriptional regulation by micrornas: are the answers in sight?. Nat Rev Genet 2008, 9(2):102-114.
4. Bartel DP.Micrornas: target recognition and regulatory functions. Cell 2009, 136(2):215-233.
5. Mercer TR, Dinger ME, Mattick JS. Long non-coding rnas: insights into functions. Nat Rev Genet 2009, 10(3):155-159.
6. Koziol MJ, Rinn JL.Rna traffic control of chromatin complexes. Curr Opin Genet Dev 2010, 20(2):142-148.
7. Lee RC, Feinbaum RL, Ambros V. The c. elegans heterochronic gene lin-4 encodes small rnas with antisense complementarity to lin-14. Cell 1993, 75(5):843-854.
8. Brennecke J, Hipfner DR, Stark A, Russell RB, Cohen SM.bantam encodes a developmentally regulated microrna that controls cell proliferation and regulates the proapoptotic gene hid in drosophila. Cell 2003, 113(1):25-36.
9. Garzon R, Calin GA, Croce CM. Micrornas in cancer. Annu Rev Med 2009, 60:167-179.
10. Iorio MV, Visone R, Di Leva G, Donati V, Petrocca F, Casalini P, Taccioli C, Volinia S, Liu C-G, Alder H, Calin GA, Ménard S, Croce CM. Microrna signatures in human ovarian cancer. Cancer Res 2007, 67(18):8699-8707.
11. Spizzo R, Nicoloso MS, Croce CM, Calin GA.Snapshot: micrornas in cancer. Cell 2009, 137(3):586-5861.
12. Gaur A, Jewell DA, Liang Y, Ridzon D, Moore JH, Chen C, Ambros VR, Israel MA. Characterization of microrna expression levels and their biological correlates in human cancer cell lines. Cancer Res 2007, 67(6):2456-2468.
13. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, Golub TR. Microrna expression profiles classify human cancers. Nature 2005, 435(7043):834-838.
14. Ma L, Teruya-Feldstein J, Weinberg RA. Tumour invasion and metastasis initiated by microrna-10b in breast cancer. Nature 2007, 449(7163):682-688.
15. He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S, Powers S, Cordon-Cardo C, Lowe SW, Hannon GJ, Hammond SM. A microrna polycistron as a potential human oncogene. Nature 2005, 435(7043):828-833.
16. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, Rassenti L, Kipps T, Negrini M, Bullrich F, Croce CM.Frequent deletions and down-regulation of micro- rna genes mir15 and mir16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002, 99(24):15524-15529.
17. Lujambio A, Ropero S, Ballestar E, Fraga MF, Cerrato C, Setién F, Casado S, Suarez-Gauthier A, Sanchez-Cespedes M, Git A, Gitt A, Spiteri I, Das PP, Caldas C, Miska E, Esteller M. Genetic unmasking of an epigenetically silenced microrna in human cancer cells. Cancer Res 2007, 67(4):1424-1429.
18. Saito Y, Liang G, Egger G, Friedman JM, Chuang JC, Coetzee GA, Jones PA.Specific activation of microrna-127 with downregulation of the proto-oncogene bcl6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 2006, 9(6):435-443.
19. Cesana M, Cacchiarelli D, Legnini I, Santini T, Sthandier O, Chinappi M, Tramontano A, Bozzoni I. A long noncoding rna controls muscle differentiation by functioning as a competing endogenous {RNA}. Cell 2011, 147(2):358-369.
20. Franco-Zorrilla JM, Valli A, Todesco M, Mateos I, Puga MI, Rubio-Somoza I, Leyva A, Weigel D, García JA, Paz-Ares J. Target mimicry provides a new mechanism for regulation of microrna activity. Nat Genet 2007, 39(8):1033-1037.
21. Ebert MS, Neilson JR, Sharp PA. Microrna sponges: competitive inhibitors of small rnas in mammalian cells. Nat Methods 2007, 4(9):721-726.
22. Poliseno L, Salmena L, Zhang J, Carver B, Haveman WJ, Pandolfi PP. A coding-independent function of gene and pseudogene mrnas regulates tumour biology. Nature 2010, 465(7301):1033-1038.
23. Hansen TB, Jensen TI, Clausen BH, Bramsen JB, Finsen B, Damgaard CK, Kjems J.Natural rna circles function as efficient microrna sponges. Nature 2013, 495(7441):384-388.
24. Memczak S, Jens M, Elefsinioti A, Torti F, Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer M, Loewer A, Ziebold U, Landthaler M, Kocks C, le Noble F, Rajewsky N. Circular rnas are a large class of animal rnas with regulatory potency. Nature 2013, 495(7441):333-338.
25. Sumazin P, Yang X, Chiu H-S, Chung W-J, Iyer A, Llobet-Navas D, Rajbhandari P, Bansal M, Guarnieri P, Silva J, Califano A.An extensive microrna-mediated network of rna-rna interactions regulates established oncogenic pathways in glioblastoma. Cell 2011, 147(2):370-381.
26. Ponting CP, Oliver PL, Reik W.Evolution and functions of long noncoding rnas. Cell 2009, 136(4):629-641.
27. Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP. A cerna hypothesis: the rosetta stone of a hidden rna language?. Cell 2011, 146(3):353-358.
28. Beroukhim R, Mermel CH, Porter D, Wei G, Raychaudhuri S, Donovan J, Barretina J, Boehm JS, Dobson J, Urashima M, Mc Henry KT, Pinchback RM, Ligon AH, Cho Y-J, Haery L, Greulich H, Reich M, Winckler W, Lawrence MS, Weir BA, Tanaka KE, Chiang DY, Bass AJ, Loo A, Hoffman C, Prensner J, Liefeld T, Gao Q, Yecies D, Signoretti S, et al. The landscape of somatic copy-number alteration across human cancers. Nature 2010, 463(7283):899-905.
29. Futreal PA, Coin L, Marshall M, Down T, Hubbard T, Wooster R, Rahman N, Stratton MR. A census of human cancer genes. Nat Rev Cancer 2004, 4(3):177-183.
30. Stratton MR, Campbell PJ, Futreal PA.The cancer genome. Nature 2009, 458(7239):719-724.
31. Nagano T, Fraser P. No-nonsense functions for long noncoding rnas. Cell 2011, 145(2):178-181.
32. Korpal M, Lee ES, Hu G, Kang Y. The mir-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of e-cadherin transcriptional repressors zeb1 and zeb2. J Biol Chem 2008, 283(22):14910-14914.
33. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y, Goodall GJ. The mir-200 family and mir-205 regulate epithelial to mesenchymal transition by targeting zeb1 and sip1. Nat Cell Biol 2008, 10(5):593-601.
34. Iliopoulos D, . Polytarchoua, C SK An integrated transcriptional regulatory circuit that reinforces the breast cancer stem cell state. PNAS 2012, 109(36):14470-14475. Polytarchoua, C SK.
35. Manavalan TT, Teng Y, Litchfield LM, Muluhngwi P, Al-Rayyan N, Klinge CM. Reduced expression of mir-200 family members contributes to antiestrogen resistance in ly2 human breast cancer cells. PLoS One 2013, 8(4):62334.
36. Yao C-X, Wei Q-X, Zhang Y-Y, Wang W-P, Xue L-X, Yang F, Zhang S-F, Xiong C-J, Li W-Y, Wei Z-R, Zou Y, Zang M-X. mir-200b targets gata-4 during cell growth and differentiation. RNA Biol 2013, 10(4):465-800.
37. Lim Y, Wright JA, Attema JL, Gregory PA, Bert AG, Smith E, Thomas D, Drew PA, Khew-Goodall Y, Goodall GJ. Epigenetic modulation of the mir-200 family is associated with transition to a breast cancer stem cell-like state. J Cell Sci 2013, 126:2256-2266. doi:10.1242/jcs.122275.
38. Yu Y, Wu J, Guan L, Qi L, Tang Y, Ma B, Zhan J, Wang Y, Fang W, Zhang H. Kindlin 2 promotes breast cancer invasion via epigenetic silencing of the microrna200 gene family. Int J Cancer 2013, 133(6):1368-13679.
39. Castilla M, Díaz-Martín J, Romero-Pérez L, López-García M, Vieites B, Biscuola M, Ramiro-Fuentes S, Isacke CM, Palacios J, . Sarrió D Microrna-200 family modulation in distinct breast cancer phenotypes. PLoS One 2012, 7(10):47709. Sarrió D.
40. Wang G, Guo X, Hong W, Liu Q, Wei T, Lu C, Gao L, Ye D, Zhou Y, Chen J, Wang J, Wu M, Liu H, Kang J. Critical regulation of mir-200/zeb2 pathway in oct4/sox2-induced mesenchymal-to-epithelial transition and induced pluripotent stem cell generation. Proc Natl Acad Sci U S A 2013, 110(8):2858-2863.
41. Balik V, Srovnal J, Sulla I, Kalita O, Foltanova T, Vaverka M, Hrabalek L, Hajduch M. Meg3: a novel long noncoding potentially tumour-suppressing rna in meningiomas. J Neurooncol 2013, 112(1):1-8.
42. Braconi C, Kogure T, Valeri N, Huang N, Nuovo G, Costinean S, Negrini M, Miotto E, Croce CM, Patel T. microrna-29 can regulate expression of the long non-coding rna gene meg3 in hepatocellular cancer. Oncogene 2011, 30(47):4750-4756.
43. Wang P, Ren Z, Sun P. Overexpression of the long non-coding rna meg3 impairs in vitro glioma cell proliferation. J Cell Biochem 2012, 113(6):1868-1874.
44. Hanahan D, Coussens LM. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell 2012, 21(3):309-322.
45. Yamano Y, Asano A, Ohyama K, Ohta M, Nishio R, Morishima I. Expression of the ha-ras suppressor family member 5 gene in the maturing rat testis. Biosci Biotechnol Biochem 2008, 72(5):1360-1363.
46. Arbiser JL, Petros J, Klafter R, Govindajaran B, McLaughlin ER, Brown LF, Cohen C, Moses M, Kilroy S, Arnold RS, Lambeth JD. Reactive oxygen generated by nox1 triggers the angiogenic switch. Proc Natl Acad Sci U S A 2002, 99(2):715-720.
47. Bracken CP, Gregory PA, Kolesnikoff N, Bert AG, Wang J, Shannon MF, Goodall GJ. A double-negative feedback loop between zeb1-sip1 and the microrna-200 family regulates epithelial-mesenchymal transition. Cancer Res 2008, 68(19):7846-7854.
48. Burk U, Schubert J, Wellner U, Schmalhofer O, Vincan E, Spaderna S, Brabletz T. A reciprocal repression between zeb1 and members of the mir-200 family promotes emt and invasion in cancer cells. EMBO Rep 2008, 9(6):582-589.
49. Hodgson G, Hager JH, Volik S, Hariono S, Wernick M, Moore D, Nowak N, Albertson DG, Pinkel D, Collins C, Hanahan D, Gray JW. Genome scanning with array cgh delineates regional alterations in mouse islet carcinomas. Nat Genet 2001, 29(4):459-464.
50. Guan Y, Kuo W-L, Stilwell JL, Takano H, Lapuk AV, Fridlyand J, Mao J-H, Yu M, Miller MA, Santos JL, Kalloger SE, Carlson JW, Ginzinger DG, Celniker SE, Mills GB, Huntsman DG, Gray JW. Amplification of pvt1 contributes to the pathophysiology of ovarian and breast cancer. Clin Cancer Res 2007, 13(19):5745-5755.
51. Fridman JS, Lowe SW. Control of apoptosis by p53. Oncogene 2003, 22(56):9030-9040.
52. Liang Y, Liu J, Feng Z. The regulation of cellular metabolism by tumor suppressor p53. Cell Biosci 2013, 3(1):9.
53. Chimge N-O, Frenkel B. The runx family in breast cancer: relationships with estrogen signaling. Oncogene 2012, 32(17):2121-2130.
54. Blyth K, Cameron ER, Neil JC. The runx genes: gain or loss of function in cancer. Nat Rev Cancer 2005, 5(5):376-387.
55. Janes KA. Runx1 and its understudied role in breast cancer. Cell Cycle 2011, 10(20):3461-3465.
56. Liu Y-N, Lee W-W, Wang C-Y, Chao T-H, Chen Y, Chen JH. Regulatory mechanisms controlling human e-cadherin gene expression. Oncogene 2005, 24(56):8277-8290.
57. Chen L-F. Tumor suppressor function of runx3 in breast cancer. J Cell Biochem 2012, 113(5):1470-1477.
58. Asselin-Labat M-L, Sutherland KD, Vaillant F, Gyorki DE, Wu D, Holroyd S, Breslin K, Ward T, Shi W, Bath ML, Deb S, Fox SB, Smyth GK, Lindeman GJ, Visvader JE. Gata-3 negatively regulates the tumor-initiating capacity of mammary luminal progenitor cells and targets the putative tumor suppressor caspase-14. Mol Cell Biol 2011, 31(22):4609-4622.
59. Grillo G, Turi A, Licciulli F, Mignone F, Liuni S, Banfi S, Gennarino VA, Horner DS, Pavesi G, Picardi E, Pesole G. Utrdb and utrsite (release 2010): a collection of sequences and regulatory motifs of the untranslated regions of eukaryotic mrnas. Nucleic Acids Res 2010, 38(suppl 1):75-80.
60. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microrna targets. Cell 2005, 120(1):15-20.
61. Grimson A, Farh KK-H, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP. Microrna targeting specificity in mammals: determinants beyond seed pairing. Mol Cell 2007, 27(1):91-105.
62. Ellwanger DC, Büttner FA, Mewes H-W, Stümpflen V. The sufficient minimal set of mirna seed types. Bioinformatics 2011, 27(10):1346-1350.